One of the biggest barriers to the development of new medical therapies is the cost of taking a new drug from a concept in a lab to a proven treatment. Estimates of these costs range from $100-million to $1.2-billion for each new drug that makes it to market, and a substantial chunk of this funding is consumed by establishing that a drug is both safe and effective. A new initiative combining breakthroughs in research, private sector support, and a non-profit committed to regenerative medicine is dedicated to improving this process.
View the original article here: Stem cells to optimize match between patient and medication – National Post
Share this article
